Concepedia

Julie A. Lofgren

JA

Statistics

Publications

10

Citations

451

H-Index

10

Active since

1996

Affiliations

Amgen (United States)(Current)

PDL BioPharma (United States)

Julie A. Lofgren is an author at Amgen (United States) specializing in signal transduction, oncology, and life sciences.

Publications per year

1996–2017

10

Publications

10

Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing

Sandra L. Ross, Marika Sherman, Patricia McElroy et al. · PLoS ONE · 2017 · 112 citations · Full text

, , +17

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways

Anne Y. Saiki, Sean Caenepeel, Dongyin Yu et al. · Oncotarget · 2014 · 55 citations · Full text

, , +12

Binding Interaction of the Heregulinβ egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis

Jennifer T. Jones, Marcus Ballinger, Paul I. Pisacane et al. · Journal of Biological Chemistry · 1998 · 54 citations · Full text

, , +14

Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage Display

Marcus Ballinger, Jennifer T. Jones, Julie A. Lofgren et al. · Journal of Biological Chemistry · 1998 · 47 citations · Full text

, , +12

Kinetic Mechanism of AKT/PKB Enzyme Family

Xiaoling Zhang, Shiwen Zhang, Harvey Yamane et al. · Journal of Biological Chemistry · 2006 · 41 citations · Full text

, , +17

1–5 of 10